日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study

在健康受试者中，H4R抑制剂伊祖福兰的药代动力学、药效学和安全性：一项I期单次和多次递增剂量研究

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.70032
Jin, Byung Hak; Hong, Taegon; Yoo, Byung Won; Kim, Choon Ok; Kim, Dasohm; Kim, Youn Nam; Park, Min Soo
发表日期：2024
文献求助 收藏

Pharmacokinetic and pharmacodynamic drug-drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers

健康男性志愿者中依格列汀与恩格列净或达格列净的药代动力学和药效学药物相互作用

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.13566
Kim, Dasohm; Choi, Minkyu; Jin, Byung Hak; Hong, Taegon; Kim, Choon Ok; Yoo, Byung Won; Park, Min Soo
发表日期：2023
文献求助 收藏

Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects

在健康受试者中评估洛贝格列酮、恩格列净和二甲双胍之间的药代动力学相互作用

期刊:Translational and Clinical Pharmacology
影响因子:1.5
doi:10.12793/tcp.2023.31.e4
Kim, Heeyoung; Kim, Choon Ok; Park, Hyeonsoo; Park, Min Soo; Kim, Dasohm; Hong, Taegon; Shin, Yesong; Jin, Byung Hak
发表日期：2023
文献求助 收藏

Dose Optimization of Cefpirome Based on Population Pharmacokinetics and Target Attainment during Extracorporeal Membrane Oxygenation

基于群体药代动力学和体外膜肺氧合期间目标达成率的头孢吡肟剂量优化

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00249-20
Kang, Soyoung; Jang, June Young; Hahn, Jongsung; Kim, Dasohm; Lee, Jun Yeong; Min, Kyoung Lok; Yang, Seungwon; Wi, Jin; Chang, Min Jung
发表日期：2020
文献求助 收藏

The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male

在健康成年男性中，含埃索美拉唑 20 mg/碳酸氢钠 800 mg 的速释制剂的安全性、药效学和药代动力学研究

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S212491
Kim, Dasohm; Park, Min Soo; Yoo, Byung Won; Hong, Taegon; Park, Shin Jung; Kim, Choon Ok
发表日期：2019
文献求助 收藏

Comparison of pharmacokinetics and safety of fixed-dose combination of SKI306X and aceclofenac versus separate tablets in healthy subjects

在健康受试者中比较SKI306X和醋氯芬酸固定剂量组合与单独片剂的药代动力学和安全性

期刊:Translational and Clinical Pharmacology
影响因子:1.5
doi:10.12793/tcp.2017.25.4.196
Meng, Xue; Oh, Eun Sil; Park, Min Soo; Kim, Dasohm; Kim, Jeong Hoon; Kim, Choon Ok
发表日期：2017
文献求助 收藏